raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:756

Pseudohypoaldosteronism type 1

Synonyms: PHA type 1 · PHA1

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

A rare, primary form of mineralocorticoid resistance characterized by mild to profound salt wasting either restricted to the kidney (renal pseudohypoaldosteronism type 1), or generalized affecting many organs (generalized pseudohypoaldosteronism type 1). Clinical presentation is in the neonatal period with failure to thrive, vomiting and dehydration with biochemical findings of hyperkalaemia, metabolic acidosis and, elevated plasma aldosterone and renin concentration.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPseudohypoaldosteronism type 1PHA type 1 · PHA1
frPseudohypoaldostéronisme type 1= en
dePseudohypoaldosteronismus Typ 1PHA Typ 1 · PHA1
esPseudohipoaldosteronismo tipo 1PHA tipo 1 · PHA1
itPseudoipoaldosteronismo tipo 1PHA tipo 1 · PHA1
nlPseudohypoaldosteronisme type 1= en
ptPseudo-hipoaldosteronismo tipo 1Adicionar PHA tipo 1
plPseudohipoaldosteronizm typu 1PHA type 1
csPseudohypoaldosteronismus, typ 1PHA typ 1
ukПсевдогіпоальдостеронізм, тип 1PHA тип 1 · PHA1
zh假性醛固酮减少症I型PHA1型
trPsödohipoaldosteronizm tip 1PHA türü 1

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM177735BTNTvalidated
OMIM264350BTNTvalidated
ICD-10N25.8NTBTattributedvalidated
ICD-11GB90.41Especificvalidated
MONDO0019161Evalidated
UMLSC0268436Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

Children (2):

4

Genes

0 direct · 4 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
NR3C2ORPHA:171871Renal pseudohypoaldosteronism type 1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:7979ENSG000001516236009834q31.23nuclear receptor subfamily 3 group C member 216757525[PMID]_19571553[PMID]
SCNN1AORPHA:171876Generalized pseudohypoaldosteronism type 1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:10599ENSG0000011131960022812p13.31sodium channel epithelial 1 subunit alpha19571553[PMID]_23416952[PMID]_23762408[PMID]
SCNN1BORPHA:171876Generalized pseudohypoaldosteronism type 1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:10600ENSG0000016844760076016p12.2sodium channel epithelial 1 subunit beta19571553[PMID]_23426840[PMID]
SCNN1GORPHA:171876Generalized pseudohypoaldosteronism type 1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:10602ENSG0000016682860076116p12.2sodium channel epithelial 1 subunit gamma11231969[PMID]_19571553[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 100 0002.12 / 100 000United KingdomValue and classValidated24616761[PMID]
Point prevalenceUnknown—EuropeClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card